Featured Research

from universities, journals, and other organizations

Medicalizing human conditions: A growth industry -- but what does it cost?

Date:
May 19, 2010
Source:
Brandeis University
Summary:
Menopause. Normal pregnancy. Infertility. ADHD. Erectile dysfunction. Over the last several decades, these conditions have come to be defined and treated as medical problems. They've been "medicalized." In the first study of its kind, researchers used national data to estimate the costs of these and a handful of other common conditions on escalating US health care spending.

Menopause. Normal pregnancy. Infertility. ADHD. Erectile dysfunction. Over the last several decades, these conditions have come to be defined and treated as medical problems. They've been "medicalized." In the first study of its kind in the current issue of Social Science and Medicine, Brandeis researchers used national data to estimate the costs of these and a handful of other common conditions on escalating U.S. healthcare spending.

The researchers, led by Brandeis sociologist Peter Conrad, evaluated 12 conditions that had been defined as medicalized by physician organizations, and for which there were current medical spending data. The other conditions considered in the study were anxiety and behavioral disorders; body image; male pattern baldness; normal sadness; obesity; sleep disorders, and substance-related disorders.

The robust trend toward ever-greater medicalization of human conditions is undeniable, with an increasing number of medical diagnoses and treatments for behavioral problems and normal life events. Conrad and his colleagues analyzed medical spending on these disorders -- payments to hospitals, pharmacies, physicians and other health care providers -- and discovered that they accounted for $77.1 billion in medical spending in 2005 -- 3.9 percent of total domestic health care expenditures.

"We spend more on these medicalized conditions than on cancer, heart disease, or public health," said Conrad. "While medicalization is unlikely to be a key driver of skyrocketing health care costs, $77 billion represents a substantial dollar sum."

Although the study did not evaluate whether medicalization is good or bad for health and society, it demonstrates the need for understanding the societal and economic impact of growing medicalization. Conrad explained that some researchers attributed medicalization to the growth of medicine's professional jurisdiction, increased consumer demands for medical solutions, and the pharmaceutical industry expanding markets for drugs.

"By estimating the amount spent on medicalized human problems, we've raised the obvious question as to whether this spending is 'appropriate,'" said Conrad. "The next question is whether we can more directly evaluate the appropriateness of these medical interventions and consider policies that curb the growth or even shrink the amount of spending on some medicalized conditions."


Story Source:

The above story is based on materials provided by Brandeis University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Peter Conrad, Thomas Mackie, Ateev Mehrotra. Estimating the costs of medicalization. Social Science & Medicine, 2010; 70 (12): 1943 DOI: 10.1016/j.socscimed.2010.02.019

Cite This Page:

Brandeis University. "Medicalizing human conditions: A growth industry -- but what does it cost?." ScienceDaily. ScienceDaily, 19 May 2010. <www.sciencedaily.com/releases/2010/05/100517152536.htm>.
Brandeis University. (2010, May 19). Medicalizing human conditions: A growth industry -- but what does it cost?. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2010/05/100517152536.htm
Brandeis University. "Medicalizing human conditions: A growth industry -- but what does it cost?." ScienceDaily. www.sciencedaily.com/releases/2010/05/100517152536.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins